NYSE · CIK 0001604522
THQ abrdn Healthcare Opportunities Fund
Insider trading from SEC Form 4. Last filing Jul 20, 2026. Close $17.86 on Oct 12, 2026, +16% from the 52-week low and -10% from the high.
In brief
abrdn Healthcare Opportunities Fund (THQ) has 4 SEC Form 4 filings on file from 4 insiders, the latest filed on Jul 20, 2026. In the last 90 days insiders made 1 open-market buy worth $11k and 0 open-market sells worth $0, net +$11k.
4 open-market trades have been scored at THQ. The newest: Chris LaVictoire Mahai (director) bought $11k of stock on Jul 16, 2026, filed Jul 20, 2026, scored 23 (weak). The largest of the 4 shown: Todd Reit (director) bought $18k on Jan 2, 2024, scored 31 (weak). 2 insiders bought within 14 days of each other around Jan 2, 2024.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at abrdn Healthcare Opportunities Fund, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Chris LaVictoire Mahai director buy | $11k 568 shares | - | - | |
| 25Weak | Kathleen Goetz director buy | $12k 600 shares | +109% | +33% from low-3% from high | |
| 31Weak | Todd Reit director buy | $18k 1,000 shares | - | +22% from low-2% from high | |
| 31Weak | Bill Maher director buy | $18k 1,000 shares | - | +21% from low-3% from high |
Transactions
Every row filed, 4 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Chris LaVictoire Mahai director | POpen-market purchase Common Stock | +568 | $18.49 | $11k | 568 | Jul 20, 2026 |
| Apr 9, 2024 | Kathleen Goetz director | POpen-market purchase Common Stock | +600 | $19.54 | $12k | 1,148 | Apr 12, 2024 |
| Jan 2, 2024 | Todd Reit director | POpen-market purchase Common Stock | +1,000 | $18.44 | $18k | 1,000 | Jan 4, 2024 |
| Dec 28, 2023 | Bill Maher director | POpen-market purchase Common Stock | +1,000 | $18.25 | $18k | 1,000 | Jan 2, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Kathleen Goetzdirector
- Chris LaVictoire Mahaidirector
- Bill Maherdirector
- Todd Reitdirector
Questions about THQ
Answered from the filings on this page, as of the latest one.
Are insiders buying THQ?
As of Jul 20, 2026, SEC Form 4 filings show 1 open-market buy worth $11k by 1 insider and 0 open-market sells worth $0 by 0 insiders at abrdn Healthcare Opportunities Fund in the last 90 days, net +$11k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade THQ on the open market?
Chris LaVictoire Mahai (director) bought $11k of THQ on Jul 16, 2026 and filed the Form 4 on Jul 20, 2026. InsiderTell scored 23 (weak).
How many insiders file Form 4 at abrdn Healthcare Opportunities Fund?
4 people have filed a Form 4 at abrdn Healthcare Opportunities Fund, among them Kathleen Goetz (director), Chris LaVictoire Mahai (director), Bill Maher (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.